[ Price : $8.95]
The Securities and Exchange Commission agrees to accept a FibroGen payment of $1.25 million to resolve a case involving tampering ...[ Price : $8.95]
A Clinical Trials Transformation Initiative meeting summary highlights four key issues discussed at its session on the state of cl...[ Price : $8.95]
FDA schedules an 11/6 Digital Health Advisory Committee meeting to examine the rise of generative artificial intelligence in digit...[ Price : $8.95]
Capsida Biotherapeutics stops enrollment in its SYNRGY clinical trial that is evaluating gene therapy CAP-002 for treating STXBP1 ...[ Price : $8.95]
FDA commissioner Marty Makary reinstates CBER director Vinay Prasads previous additional duties as the agencys chief medical and s...[ Price : $8.95]
FDA approves an expanded indication to include pediatric patients aged one and older for AstraZenecas Koselugo to treat some cases...[ Price : $8.95]
FDA publishes a draft guidance to assist in developing non-opioid analgesics to treat chronic pain.[ Price : $8.95]
FDA clears a new indication for neurocare groups Apollo TMS therapy device to treat adolescents with major depressive disorder.